| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |